Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 05 04; 141(18):2194-2205.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Azacitidine
Cyclophosphamide
Doxorubicin
Humans
Immunologic Factors
Lymphoma, T-Cell, Peripheral
Prednisone
Tumor Microenvironment
Vincristine
authors with profiles
Koen Van Besien